A detailed history of Roosevelt Investment Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Roosevelt Investment Group LLC holds 3,568 shares of NVO stock, worth $373,070. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,568
Previous 3,568 -0.0%
Holding current value
$373,070
Previous $398,000 10.8%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $11,172 - $13,504
-120 Reduced 3.25%
3,568 $396,000
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $5,752 - $7,024
60 Added 1.65%
3,688 $413,000
Q2 2021

Aug 11, 2021

SELL
$67.66 - $84.76 $20,298 - $25,428
-300 Reduced 7.64%
3,628 $304,000
Q1 2021

May 04, 2021

SELL
$67.06 - $75.82 $13,412 - $15,163
-200 Reduced 4.84%
3,928 $265,000
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $7,986 - $9,225
-125 Reduced 2.94%
4,128 $288,000
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $7,961 - $8,777
125 Added 3.03%
4,253 $295,000
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $8,371 - $9,715
143 Added 3.59%
4,128 $270,000
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $24,730 - $32,390
-500 Reduced 11.15%
3,985 $240,000
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $67,061 - $78,359
-1,345 Reduced 23.07%
4,485 $260,000
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $12,835 - $14,426
270 Added 4.86%
5,830 $301,000
Q2 2019

Aug 08, 2019

SELL
$46.79 - $52.47 $70,185 - $78,705
-1,500 Reduced 21.25%
5,560 $284,000
Q2 2018

Aug 10, 2018

SELL
$44.29 - $50.42 $41,145 - $46,840
-929 Reduced 11.63%
7,060 $326,000
Q1 2018

May 08, 2018

SELL
$48.49 - $58.14 $64,249 - $77,035
-1,325 Reduced 14.23%
7,989 $393,000
Q3 2017

Nov 08, 2017

SELL
$41.15 - $49.22 $12,797 - $15,307
-311 Reduced 3.23%
9,314 $448,000
Q2 2017

Aug 10, 2017

BUY
N/A
9,625
9,625 $413,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Roosevelt Investment Group LLC Portfolio

Follow Roosevelt Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roosevelt Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roosevelt Investment Group LLC with notifications on news.